Issue Type: Abuses of Government Programs and Regulations
In challenge narrative 12/9/20
-
Solving Pharma’s Shkreli Problem
-
Rising Drug Costs Only Getting Worse
-
Express Scripts Turns to a Compounder to Avoid a Turing Drug
-
Remdesivir Less Expensive for “Government Programs”? Not So Fast.
-
Expansion of the Medicare 340B Payment Program
-
Impact of President Trump’s Proposed 340B Hospital Eligibility Threshold
-
Association of Rebates in Part D with Patient OOP and Federal Spending
-
The 340B Program: Hospitals Profit by Reaching Affluent Communities
-
Cost Consequences of the 340B Drug Discount Program
-
Limits on Medicare’s Ability to Control Rising Spending on Cancer Drugs